Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (AAVXF) Interest & Investment Income (2024 - 2025)

Historic Interest & Investment Income for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to $23.9 million.

  • Abivax's Interest & Investment Income rose 53213.23% to $23.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.8 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 8060.73% up from last year.
  • Abivax's Interest & Investment Income amounted to $23.9 million in Q3 2025, which was up 53213.23% from $4.0 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Interest & Investment Income ranged from a high of $23.9 million in Q3 2025 and a low of -$1.1 million during Q1 2025